YU58386A - Process for obtaining tablets - Google Patents

Process for obtaining tablets

Info

Publication number
YU58386A
YU58386A YU00583/86A YU58386A YU58386A YU 58386 A YU58386 A YU 58386A YU 00583/86 A YU00583/86 A YU 00583/86A YU 58386 A YU58386 A YU 58386A YU 58386 A YU58386 A YU 58386A
Authority
YU
Yugoslavia
Prior art keywords
obtaining tablets
tablets
obtaining
Prior art date
Application number
YU00583/86A
Other languages
English (en)
Inventor
S Bolton
S Desai
Original Assignee
Forest Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forest Laboratories filed Critical Forest Laboratories
Publication of YU58386A publication Critical patent/YU58386A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU00583/86A 1985-04-12 1986-04-11 Process for obtaining tablets YU58386A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72283285A 1985-04-12 1985-04-12

Publications (1)

Publication Number Publication Date
YU58386A true YU58386A (en) 1987-10-31

Family

ID=24903574

Family Applications (1)

Application Number Title Priority Date Filing Date
YU00583/86A YU58386A (en) 1985-04-12 1986-04-11 Process for obtaining tablets

Country Status (8)

Country Link
US (1) US4814179A (ru)
JP (1) JPS61246120A (ru)
BE (1) BE904899A (ru)
DK (1) DK162986A (ru)
ES (2) ES8800594A1 (ru)
PL (1) PL149493B1 (ru)
SU (1) SU1679965A3 (ru)
YU (1) YU58386A (ru)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
IN186245B (ru) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
DE10014588A1 (de) 2000-03-27 2001-10-04 Basf Ag Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US20060099245A1 (en) * 2000-08-01 2006-05-11 Manoj Kumar Hydrodynamically balancing oral drug delivery system with biphasic release
AU2008255254B2 (en) * 2001-03-31 2010-12-09 Jagotec Ag A pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance and respective processes of producing same and a cup-shaped envelope of same
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
WO2003037301A2 (en) * 2001-10-29 2003-05-08 King Pharmaceuticals Research And Development, Inc Oral dosage forms for improving the bioavailability of therapeutic agents
BE1015608A6 (fr) * 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
WO2003089506A1 (en) * 2002-04-22 2003-10-30 Purdue Research Foundation Hydrogels having enhanced elasticity and mechanical strength properties
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
NZ523946A (en) * 2003-01-31 2004-06-25 Carl Ernest Alexander Portable hygiene compositions comprising a semi-solid gel and active ingredients in bead form for use in personal oral, dental or skin care
ES2278314T3 (es) * 2003-04-17 2007-08-01 Jallal Messadek Formulaciones orales para la liberacion controlada de la betaina.
US20060128657A1 (en) * 2003-08-04 2006-06-15 Jallal Messadek Selected betaines and their uses
BE1016128A6 (fr) * 2004-07-22 2006-03-07 Messadek Jallal Combinaisons therapeutiques
WO2006050581A2 (en) * 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
EP2242489A1 (en) 2005-02-15 2010-10-27 Jallal Messadek Combination therapeutic compositions and method of use
MX2007013486A (es) * 2005-04-27 2008-03-14 Jallal Messadek Combinaciones de insulinas.
US20070178155A1 (en) * 2006-01-31 2007-08-02 Jiang David Yihai Preparation for gastric buoyant sustained drug release dosage form
AT505225A1 (de) 2007-04-26 2008-11-15 Sanochemia Pharmazeutika Ag 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen
WO2009065193A1 (en) * 2007-11-21 2009-05-28 Jallal Messadek Treatment of aspirin resistance with betaine and/or betaine enriched molasses
EP2133071A1 (en) * 2008-06-09 2009-12-16 Université de la Méditerranée Process for making gastroretentive dosage forms
US20100249423A1 (en) * 2009-03-09 2010-09-30 Sanochemia Pharmazeutika Ag Tolperisone controlled release tablet
EP2444064A1 (en) 2010-10-22 2012-04-25 Meliatys Process for making multiparticulate gastroretentive dosage forms
WO2013142482A1 (en) 2012-03-20 2013-09-26 Particle Dynamics International, Llc Gelling agent-based dosage form
HUE025008T2 (en) 2012-10-12 2016-04-28 Omya Int Ag Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
PL235144B1 (pl) 2014-06-03 2020-06-01 Univ Medyczny Im Piastow Slaskich We Wroclawiu Sposób wytwarzania tabletki flotacyjnej o przedłużonym oddziaływaniu substancji leczniczych z błoną śluzową żołądka oraz kompozycja farmaceutyczna
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
CA3001337C (en) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
US11389398B2 (en) 2019-05-14 2022-07-19 Clexio Biosciences Ltd. Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3323922A (en) * 1965-08-09 1967-06-06 Pillsbury Co Protective coatings
US3483002A (en) * 1966-11-15 1969-12-09 Kohnstamm & Co Inc H Gelatinous coloring composition and process
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4089981A (en) * 1976-06-04 1978-05-16 Maxfibe Foods, Inc. Fibrous simulated food product with gel structure
US4434153A (en) * 1982-03-22 1984-02-28 Alza Corporation Drug delivery system comprising a reservoir containing a plurality of tiny pills
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
FR2537844B1 (fr) * 1982-12-17 1985-08-23 Roquette Freres Pastilles du type lozenge a base de sorbitol ou de fructose cristallise et leur procede de fabrication
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier

Also Published As

Publication number Publication date
DK162986D0 (da) 1986-04-10
ES557776A0 (es) 1988-07-16
DK162986A (da) 1986-10-13
US4814179A (en) 1989-03-21
PL149493B1 (en) 1990-02-28
SU1679965A3 (ru) 1991-09-23
ES8802466A1 (es) 1988-07-16
JPS61246120A (ja) 1986-11-01
BE904899A (fr) 1986-10-01
ES553900A0 (es) 1987-11-01
ES8800594A1 (es) 1987-11-01

Similar Documents

Publication Publication Date Title
YU58386A (en) Process for obtaining tablets
YU154986A (en) Process for obtaining bis-phosphitic compounds
YU44294B (en) Process for obtaining new antihypertenzic compounds
YU116787A (en) Process for obtaining imidazochynolinic derivatives
YU183586A (en) Process for obtaining chynoline derivatives
YU131088A (en) Process for obtaining 1-terciaric-alkyl-substituted naphtiridine- and hynolin-carboxylic intermediers
YU99386A (en) Process for obtaining new thienopyridones
EP0199997A3 (en) Process for preparing diaryl-pentaerythritol
YU202686A (en) Process for obtaining hynolone
YU45469B (en) Process for obtaining imidazolylalkylguanidinic derivatives
YU105287A (en) Process for obtaining specific 3-benzole-4-oxolactame
PT83293B (en) Process for preparing dihidropyridine-2-hydroxyamines useful asmedicaments
HUT44172A (en) Process for producing tablets
PT83154A (en) Process for preparing quinolizinesulphonamides
GB8618212D0 (en) Tablets
ZA863454B (en) Process for preparing benzothiazolesulphenamides
HUT42766A (en) Process for preparing n-sulfamyl-3-(2-guanidino-thiazolyl-4-methyl-thio)-propionamidine
YU100886A (en) Process for obtaining 2-bromine-alpha-ergocriptine
HUT43022A (en) Process for preparing monochloro-pinacolone
YU118187A (en) Process for obtaining mercaptoacylproline
HUT43039A (en) Process for preparing 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
HUT42769A (en) Process for preparing pyridazodiazepines
YU179288A (en) Process for obtaining anilynoforumates
EP0213594A3 (en) Polymerflood process
YU107986A (en) Process for obtaining 2-halonicergilinic derivatives